Aspire Biopharma Holdings, Inc.
USD5.17
-0.88 (-14.53%)
CEO
Kraig T. Higginson
IPO Date
2025-02-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.41
Prev. Close
$6.05
Day Low
$4.65
Day High
$6.41
52W Low
$0.11
52W High
$35.00
Market Cap
$0.00B
Volume
0.22M
| -759.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 22.8% | 22.3% | 0.00 | 0.20 | 1403.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 1.2% | 1.1% | 0.00 | 3.62 | 3324.8 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 5363.2% | -8.7% | -502.31 | 1.00 | -321317.0 |
| -12.6 |
| 30 Sept 2025 | Q3 | 45.5% | -95337.1% | 16.1% | -77.0% | -0.12 | 0.17 | -41.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 20.6% | -200.2% | -0.19 | 0.09 | -50.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 229.3% | -811.1% | -0.25 | 0.22 | -10.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 579.9% | -6034.9% | -0.82 | 0.09 | -266.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -594.8% | -8.1% | 4.83 | 0.01 | -4706.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -96.0% | -8.8% | 8.54 | 0.05 | -3875.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -14.0% | -12.2% | 0.11 | 0.02 | -927.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -0.8% | -0.8% | 0.00 | 0.20 | -13774.0 |